← Leaderboards
Yuqiang Wang
Panorama Research, Inc.
$1,224,491
Attributed
$1,224,491
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,224,491 · 5
By mechanism
R43$840,392 · 4
R44$384,099 · 1
Top collaborators
No co-investigators on record.
Most similar at Panorama Research, Inc.
Same institution · by research overlap
- James W Larrick$19,609,694
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionLaboratory MouseDrug Screening /EvaluationChemical SynthesisAntineoplasticsCytotoxicityTissue /Cell CultureOmega 3 Fatty AcidPharmacokineticsProdrugsChemical ConjugateLeukemiaLung NeoplasmsMembrane PotentialsElectrophysiologyNeoplastic CellNeuroprotectantsNmda ReceptorsCationsNitric OxideNitroneNuclear Magnetic Resonance SpectroscopyPaclitaxelReceptor Binding
Grant awards (6)
Novel Tumor-selective Anticancer Agents$146,000
R43 · FY2004 · CA
Synthesis and Evaluation of Novel Antitumor Agents$100,000
R43 · FY2003 · CA
SYNTHESIS AND EVALUTATION OF CATIONIC ANTITUMOR AGENTS$250,000
R43 · FY2002 · CA
Novel NMDA Receptor-Binding Drugs for Ischemia/Stroke$100,000
R43 · FY2002 · NS
SYNTHESIS AND EVALUTATION OF CATIONIC ANTITUMOR AGENTS$244,392
R43 · FY2001 · CA
NOVEL NMDA RECEPTOR ANTAGONISTS FOR HIV NEUROINJURY$384,099
R44 · FY2000 · MH